Last reviewed · How we verify
Kera Sol Eye Drops
Kera Sol Eye Drops is a lubricating ophthalmic solution designed to provide moisture and relief to dry eyes.
Kera Sol Eye Drops is a lubricating ophthalmic solution designed to provide moisture and relief to dry eyes. Used for Dry eye disease / Keratoconjunctivitis sicca.
At a glance
| Generic name | Kera Sol Eye Drops |
|---|---|
| Sponsor | Vance Thompson Vision |
| Drug class | Artificial tear / Lubricating eye drop |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | FDA-approved |
Mechanism of action
The product functions as an artificial tear substitute that hydrates the ocular surface and helps maintain tear film stability. It is formulated to mimic natural tears and provide symptomatic relief for dry eye disease by reducing friction and protecting the corneal epithelium.
Approved indications
- Dry eye disease / Keratoconjunctivitis sicca
Common side effects
- Ocular irritation
- Temporary blurred vision
- Eye discomfort
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Kera Sol Eye Drops CI brief — competitive landscape report
- Kera Sol Eye Drops updates RSS · CI watch RSS
- Vance Thompson Vision portfolio CI